 | Zacks Investment Research Upgrades Albireo Pharma (NASDAQ:ALBO) to "Hold" marketbeat.com - February 17 at 3:47 PM |
 | Jan Mattsson Sells 31,470 Shares of Albireo Pharma, Inc. (NASDAQ:ALBO) Stock americanbankingnews.com - March 3 at 9:08 PM |
 | Albireo Pharma, Inc. (NASDAQ:ALBO) to Post Q1 2021 Earnings of ($1.66) Per Share, Piper Sandler Forecasts americanbankingnews.com - March 3 at 8:07 AM |
 | Albireo Pharma (NASDAQ:ALBO) Stock Price Up 6.8% Following Analyst Upgrade americanbankingnews.com - March 1 at 6:14 PM |
 | Albireo Pharma (NASDAQ:ALBO) Price Target Raised to $81.00 americanbankingnews.com - March 1 at 10:59 AM |
 | Analyzing Eli Lilly and (NYSE:LLY) and Albireo Pharma (NASDAQ:ALBO) americanbankingnews.com - March 1 at 9:38 AM |
 | Robert W. Baird Reiterates "Buy" Rating for Albireo Pharma (NASDAQ:ALBO) americanbankingnews.com - March 1 at 9:05 AM |
 | Albireo Pharma, Inc. (ALBO) CEO Ron Cooper on Q4 2020 Results - Earnings Call Transcript seekingalpha.com - February 27 at 9:47 AM |
 | Industry Analysts Just Made A Captivating Upgrade To Their Albireo Pharma, Inc. (NASDAQ:ALBO) Revenue Forecasts finance.yahoo.com - February 27 at 9:47 AM |
 | Albireo Pharma (NASDAQ:ALBO) Issues Earnings Results americanbankingnews.com - February 26 at 5:16 PM |
|
 | Albireo Spotlights Global Patient Communities on Rare Disease Day finance.yahoo.com - February 26 at 9:05 AM |
 | Albireo Pharma, Inc. (ALBO) Q4 2020 Earnings Call Transcript msn.com - February 26 at 12:40 AM |
 | Albireo Pharma, Inc. 2020 Q4 - Results - Earnings Call Presentation seekingalpha.com - February 25 at 4:07 PM |
 | Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update finance.yahoo.com - February 25 at 9:39 AM |
 | Albireo to Participate in Cowen and H.C. Wainwright Global Investor Conferences finance.yahoo.com - February 23 at 9:34 AM |
 | Albireo Pharma (ALBO) Scheduled to Post Earnings on Thursday americanbankingnews.com - February 19 at 10:44 AM |
 | Albireo to Report Q4 and Year-End 2020 Financial Results on February 25 finance.yahoo.com - February 18 at 8:46 AM |
 | Did Albireo Pharma's (NASDAQ:ALBO) Share Price Deserve to Gain 81%? finance.yahoo.com - February 5 at 10:21 AM |
 | Albireo Pharma: De-Risked Small-Cap Biotech Ready For Commercialization seekingalpha.com - January 27 at 7:12 AM |
 | Albireo to Participate in H.C. Wainwright BioConnect and LifeSci Advisors Investor Conferences finance.yahoo.com - January 5 at 8:58 AM |
 | Is ALBO A Good Stock To Buy Now? finance.yahoo.com - December 19 at 6:54 PM |
 | Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome finance.yahoo.com - December 17 at 9:38 AM |
 | Albireo Submits for U.S. FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC finance.yahoo.com - December 8 at 4:39 PM |
 | The Petri Dish: Wyss Institute's VC partnership and a health tech firm eyes M&A bizjournals.com - November 19 at 8:09 AM |
 | Albireo Pharma's odevixibat shows durable response in a rare pediatric liver disease seekingalpha.com - November 13 at 9:31 PM |
 | Albireo to Participate in Jefferies and Piper Sandler Virtual Investor Conferences finance.yahoo.com - November 12 at 1:03 PM |
 | The Albireo Pharma, Inc. (NASDAQ:ALBO) Third-Quarter Results Are Out And Analysts Have Published New Forecasts nasdaq.com - November 7 at 12:42 PM |
 | Albireo Pharma, Inc. (NASDAQ:ALBO) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? finance.yahoo.com - November 7 at 7:39 AM |
 | Albireo Pharma EPS misses by $0.45, beats on revenue seekingalpha.com - November 5 at 10:00 AM |
 | Albireo Reports Q3 2020 Financial Results and Provides Business Update finance.yahoo.com - November 5 at 10:00 AM |
|
 | Albireo’s Odevixibat PFIC Phase 3 Results Accepted for AASLD Late-Breakers finance.yahoo.com - November 2 at 12:31 PM |
 | Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting finance.yahoo.com - October 23 at 9:52 AM |
 | Insider Buys Albireo Pharma's Shares finance.yahoo.com - September 15 at 7:31 PM |
 | Insider Buys Albireo Pharma's Shares benzinga.com - September 15 at 2:30 PM |
 | Albireo's Positive Data, And Other News: The Good, Bad And Ugly Of Biopharma seekingalpha.com - September 11 at 7:49 AM |
 | Albireo Prices Public Offering of 4,000,000 Shares of Common Stock finance.yahoo.com - September 10 at 5:32 AM |
 | Albireo Announces Proposed Public Offering of 3,000,000 Shares of Common Stock finance.yahoo.com - September 8 at 6:50 PM |
 | Mid-Morning Market Update: Markets Open Lower; Grifols To Buy Geriatric Pharma Startup Alkahest benzinga.com - September 8 at 1:50 PM |
 | Albireo up 10% ahead of late-stage odevixibat data readout seekingalpha.com - September 8 at 8:49 AM |
 | Albireo Phase 3 Trial Meets Both Primary Endpoints for Odevixibat in PFIC finance.yahoo.com - September 8 at 8:49 AM |
 | Is the Options Market Predicting a Spike in Albireo Pharma (ALBO) Stock? finance.yahoo.com - September 3 at 10:29 AM |
 | How Much Of Albireo Pharma, Inc. (NASDAQ:ALBO) Do Institutions Own? finance.yahoo.com - August 27 at 8:37 AM |
 | Albireo (ALBO) Looks Good: Stock Adds 5.1% in Session finance.yahoo.com - August 21 at 2:22 PM |
 | Albireo Down on Unimpressive Data From Mid-Stage NASH Study finance.yahoo.com - August 19 at 3:16 PM |
 | Albireo under pressure on elobixibat strikeout in NASH seekingalpha.com - August 18 at 5:56 PM |
 | Albireo Reports Topline Results from Phase 2 Trial of Elobixibat in NAFLD/NASH finance.yahoo.com - August 18 at 5:56 PM |
 | Albireo Corporate Updates, And Other News: The Good, Bad And Ugly Of Biopharma seekingalpha.com - August 10 at 11:43 PM |
 | Albireo Pharma, Inc.'s (ALBO) CEO Ron Cooper on Q2 2020 Results - Earnings Call Transcript seekingalpha.com - August 8 at 5:39 PM |
 | Albireo Pharma, Inc. (ALBO) Q2 2020 Earnings Call Transcript fool.com - August 7 at 6:48 PM |
 | Albireo Pharma EPS beats by $0.28, beats on revenue seekingalpha.com - August 6 at 12:35 PM |
 | Albireo Reports Q2 2020 Financial Results and Provides Business Update finance.yahoo.com - August 6 at 7:35 AM |